Skip to content

Top 10 Companies By Orphan Drug Sales

August 13, 2014

In an article, “Biotech Report: Ultra Man”, from the August 2014 issue of Medical Marketing & Media, the publication reviews and discusses the following topics for ultra-rare disease products :

•   Top 10 Companies by orphan drug sales for 2013

•   Top 10 orphan drugs by sales for 2013

•   Discussion with Eric Pauwels, President of NPS Pharma International, as to how pharmaceutical companies can demonstrate the value of ultra-rare disease products for securing insurance coverage

•   Evaluation of successes and pitfalls of recent orphan therapy launches:

1.   Vertex Pharmaceutials’ Kalydeco for Cystic Fibrosis
2   Genzyme’s Kynamro for Homozygous Familial Hypercholesterolemia (HoFH)
3.   KV Pharmaceuticals’ Makena to reduce risk of preterm birth
4.   Alexion Pharmaceutials’ Soliris for Paroxysmal Nocturnal Hemoglobinuria (PNH) & Atypical Hemolytic Uremic Syndrome (aHUS).

The following chart from the MM&M article identifies the top 10 companies by orphan drug sales for 2013:

Top 10 Companies By Orphan Drug Sales (2013)

Rank Company Global Sales ($ Billions) *
1 Novartis $ 11.4
2 Roche $ 9.5
3 Celgene $ 5.6
4 Pfizer $ 5.2
5 Teva $ 5.1
6 Bayer $ 4.1
7 Sanofi $ 3.2
8 Merck KGaA $ 3.0
9 Biogen Idec $ 3.0
10 Baxter International $ 2.9

* Sales, EvaluatePharma (per MM&M article chart)

.

Please Note: “Abstract pills” by Robson# (Flickr: Pills here) [CC-BY-2.0] | Wikimedia Commons.

Copyright © 2012-2014, Orphan Druganaut Blog. All rights reserved.

Advertisements
2 Comments
  1. As always, helpful and informative. However, it is worth noting that Kynamro is marketed by Genzyme, not Aegerion.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

%d bloggers like this: